{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T05:41:03Z","timestamp":1777873263887,"version":"3.51.4"},"reference-count":38,"publisher":"International Society of Global Health","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Glob Health"],"DOI":"10.7189\/jogh.16.04051","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:41:58Z","timestamp":1777563718000},"source":"Crossref","is-referenced-by-count":0,"title":["Impact and cost-effectiveness of two interventions to prevent paediatric respiratory syncytial virus disease in Cameroon: a modelling approach"],"prefix":"10.7189","volume":"16","author":[{"given":"Farina Leonie","family":"Shaaban","sequence":"first","affiliation":[{"name":"Department of Paediatrics, University Medical Centre Utrecht, Utrecht, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert","family":"Fuhngwa","sequence":"additional","affiliation":[{"name":"Triangle Research Foundation Douala, Cameroon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henshaw","family":"Mandi","sequence":"additional","affiliation":[{"name":"Triangle Research Foundation Douala, Cameroon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Clark","sequence":"additional","affiliation":[{"name":"Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neele","family":"Rave","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, University Medical Centre Utrecht, Utrecht, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clint","family":"Pecenka","sequence":"additional","affiliation":[{"name":"Center for Vaccine Innovation and Access, PATH, Seattle, Washington, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis J","family":"Bont","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, University Medical Centre Utrecht, Utrecht, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Debellut","sequence":"additional","affiliation":[{"name":"Center for Vaccine Innovation and Access, PATH, Geneva, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"RSV GOLD III \u2013 Health Economics Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4223","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"key-10.7189\/jogh.16.04051-202604301951-R1","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S0140-6736(19)30721-4","article-title":"Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study.","volume":"394","author":"Pneumonia Etiology Research for Child Health (PERCH) Study Group","year":"2019","journal-title":"Lancet"},{"key":"key-10.7189\/jogh.16.04051-202604301951-R2","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/S0140-6736(22)00478-0","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis.","volume":"399","author":"Li","year":"2022","journal-title":"Lancet"},{"key":"key-10.7189\/jogh.16.04051-202604301951-R3","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/irv.12391","article-title":"Viral etiology of severe acute respiratory infections in hospitalized children in Cameroon, 2011\u20132013.","volume":"10","author":"Kenmoe","year":"2016","journal-title":"Influenza Other Respir Viruses"},{"key":"key-10.7189\/jogh.16.04051-202604301951-R4","doi-asserted-by":"publisher","first-page":"e13131","DOI":"10.1111\/irv.13131","article-title":"Viral co-infection with human respiratory syncytial virus in suspected acute and severe respiratory tract infections during COVID-19 pandemic in Yaound\u00e9, Cameroon, 2020\u20132021.","volume":"17","author":"Moumbeket Yifomnjou","year":"2023","journal-title":"Influenza Other Respir Viruses"},{"key":"key-10.7189\/jogh.16.04051-202604301951-R5","doi-asserted-by":"publisher","first-page":"ofab159","DOI":"10.1093\/ofid\/ofab159","article-title":"The Global Epidemiology of RSV in Community and Hospitalized Care: Findings from 15 Countries.","volume":"8","author":"Staadegaard","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"key-10.7189\/jogh.16.04051-202604301951-R6","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1056\/NEJMe2312934","article-title":"RSV Prevention \u2014 Breakthroughs and Challenges.","volume":"389","author":"Halasa","year":"2023","journal-title":"N Engl J Med"},{"key":"key-10.7189\/jogh.16.04051-202604301951-R7","unstructured":"PATH. RSV vaccine and mAb snapshot. 2024. Available: https:\/\/www.path.org\/our-impact\/resources\/rsv-vaccine-and-mab-snapshot\/. Accessed: 10 April 2024."},{"key":"key-10.7189\/jogh.16.04051-202604301951-R8","unstructured":"AstraZeneca. Beyfortus approved in the EU for the prevention of RSV lower respiratory tract disease in infants. 2022. Available: https:\/\/www.astrazeneca.com\/media-centre\/press-releases\/2022\/beyfortus-approved-in-the-eu-for-the-prevention-of-rsv-lower-respiratory-tract-disease-in-infants.html. Accessed 25 April 2024."},{"key":"key-10.7189\/jogh.16.04051-202604301951-R9","unstructured":"Pfizer. European Commission Approves Pfizer\u2019s ABRYSVOTM to Help Protect Infants through Maternal Immunization and Older Adults from RSV. 2023. Available: https:\/\/www.pfizer.com\/news\/press-release\/press-release-detail\/european-commission-approves-pfizers-abrysvotm-help-protect. Accessed 10 April 2024."},{"key":"key-10.7189\/jogh.16.04051-202604301951-R10","unstructured":"World Health Organization. Meeting of the Strategic Advisory Group of Experts on Immunization, March 2024: conclusions and recommendations. Geneva, Switzerland: World Health Organization; 2024. Available: https:\/\/www.who.int\/publications\/i\/item\/WER-9922-285-306. Accessed 26 June 2024."},{"key":"key-10.7189\/jogh.16.04051-202604301951-R11","doi-asserted-by":"publisher","first-page":"961","DOI":"10.3390\/vaccines9090961","article-title":"Bringing preventive RSV monoclonal antibodies to infants in low-and middle-income countries: Challenges and opportunities.","volume":"9","author":"Ananworanich","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"key-10.7189\/jogh.16.04051-202604301951-R12","unstructured":"World Bank Group. GDP per capita (current US$) \u2013 Cameroon Data. 2024. Available: https:\/\/data.worldbank.org\/indicator\/NY.GDP.PCAP.CD?locations=CM. Accessed: 7 May 2024."},{"key":"key-10.7189\/jogh.16.04051-202604301951-R13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2018-000964","article-title":"Estimating health opportunity costs in low-income and middle-income countries: A novel approach and evidence from cross-country data.","volume":"3","author":"Ochalek","year":"2018","journal-title":"BMJ Glob Health"},{"key":"key-10.7189\/jogh.16.04051-202604301951-R14","unstructured":"Pan American Health Organization. ProVac Toolkit. 2024. Available: https:\/\/www.paho.org\/en\/provac-toolkit. Accessed: 10 April 2024."},{"key":"key-10.7189\/jogh.16.04051-202604301951-R15","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12916-023-02827-5","article-title":"Cost-effectiveness of pharmaceutical strategies to prevent respiratory syncytial virus disease in young children: a decision-support model for use in low-income and middle-income countries.","volume":"21","author":"Mahmud","year":"2023","journal-title":"BMC Med"},{"key":"key-10.7189\/jogh.16.04051-202604301951-R16","doi-asserted-by":"publisher","first-page":"6782","DOI":"10.1016\/j.vaccine.2023.09.003","article-title":"Impact and cost-effectiveness of strategies to prevent respiratory syncytial virus (RSV) disease in Vietnam: A modelling study.","volume":"41","author":"Do","year":"2023","journal-title":"Vaccine"},{"key":"key-10.7189\/jogh.16.04051-202604301951-R17","doi-asserted-by":"publisher","first-page":"04292","DOI":"10.7189\/jogh.15.04292","article-title":"Cost-effectiveness of introducing a maternal vaccine or long-acting monoclonal antibody to prevent infant respiratory syncytial virus disease in Nepal.","volume":"15","author":"Rave","year":"2025","journal-title":"J Glob Health"},{"key":"key-10.7189\/jogh.16.04051-202604301951-R18","doi-asserted-by":"publisher","first-page":"126234","DOI":"10.1016\/j.vaccine.2024.126234","article-title":"Evaluation of the potential impact and cost-effectiveness of respiratory syncytial virus (RSV) prevention strategies for infants in Argentina.","volume":"42","author":"Gui\u00f1az\u00fa","year":"2024","journal-title":"Vaccine"},{"key":"key-10.7189\/jogh.16.04051-202604301951-R19","unstructured":"Demographic and Health Surveys. R\u00e9publique du Cameroun Enqu\u00eate D\u00e9mographique et de Sant\u00e9. 2018. Available: https:\/\/dhsprogram.com\/. Accessed: 11 April 2024."},{"key":"key-10.7189\/jogh.16.04051-202604301951-R20","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1136\/thoraxjnl-2014-205249","article-title":"Essential medicines for COPD and asthma in low and middle-income countries.","volume":"69","author":"Bazargani","year":"2014","journal-title":"Thorax"},{"key":"key-10.7189\/jogh.16.04051-202604301951-R21","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/978-3-642-38919-1_20","article-title":"Challenges and Opportunities for Respiratory Syncytial Virus Vaccines.","volume":"372","author":"Graham","year":"2013","journal-title":"Curr Top Microbiol Immunol"},{"key":"key-10.7189\/jogh.16.04051-202604301951-R22","unstructured":"World Health Organization. WHO-CHOICE estimates of cost for inpatient and outpatient health service delivery. Geneva, Switzerland: World Health Organization; 2021. Available: https:\/\/www.who.int\/publications\/m\/item\/who-choice-estimates-of-cost-for-inpatient-and-outpatient-health-service-delivery. Accessed 10 April 2024."},{"key":"key-10.7189\/jogh.16.04051-202604301951-R23","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1093\/jpids\/piaa157","article-title":"Estimating the Economic Impact of Respiratory Syncytial Virus and Other Acute Respiratory Infections Among Infants Receiving Care at a Referral Hospital in Malawi.","volume":"9","author":"Baral","year":"2020","journal-title":"J Pediatric Infect Dis Soc"},{"key":"key-10.7189\/jogh.16.04051-202604301951-R24","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12916-023-02854-2","article-title":"The economic burden of RSV-associated illness in children aged < 5 years, South Africa 2011\u20132016.","volume":"21","author":"Moyes","year":"2023","journal-title":"BMC Med"},{"key":"key-10.7189\/jogh.16.04051-202604301951-R25","unstructured":"WUENIC trends. WHO\/UNICEF estimates of national immunization coverage. 2022. Available: https:\/\/worldhealthorg.shinyapps.io\/wuenic-trends\/. Accessed: 10 April 2024."},{"key":"key-10.7189\/jogh.16.04051-202604301951-R26","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1056\/NEJMc2214773","article-title":"Nirsevimab for Prevention of RSV in Term and Late-Preterm Infants.","volume":"388","author":"Muller","year":"2023","journal-title":"N Engl J Med"},{"key":"key-10.7189\/jogh.16.04051-202604301951-R27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0237718","article-title":"Inferring antenatal care visit timing in low- And middle-income countries: Methods to inform potential maternal vaccine coverage.","volume":"15","author":"Baral","year":"2020","journal-title":"PLoS One"},{"key":"key-10.7189\/jogh.16.04051-202604301951-R28","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2216480","article-title":"Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants.","volume":"388","author":"Kampmann","year":"2023","journal-title":"N Engl J Med"},{"key":"key-10.7189\/jogh.16.04051-202604301951-R29","unstructured":"United Nations International Children\u2019s Emergency Fund. UNICEF Handling fees. 2022. Available: https:\/\/www.unicef.org\/supply\/handling-fees. Accessed: 11 April 2024."},{"key":"key-10.7189\/jogh.16.04051-202604301951-R30","doi-asserted-by":"publisher","first-page":"2040329","DOI":"10.1080\/21645515.2022.2040329","article-title":"Potential impact and cost-effectiveness of injectable next-generation rotavirus vaccines in 137 LMICs: a modelling study.","volume":"18","author":"Debellut","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"key-10.7189\/jogh.16.04051-202604301951-R31","unstructured":"Immunization Costing Action Network (ICAN). 2024. Available: https:\/\/immunizationeconomics.org\/thinkwell-idcc\/. Accessed 10 April 2024."},{"key":"key-10.7189\/jogh.16.04051-202604301951-R32","unstructured":"United Nations Department of Economic and Social Affairs Population Division. World Population Prospects 2022. 2022. Available: https:\/\/population.un.org\/wpp\/Download\/Standard\/Population\/. Accessed: 10 April 2024."},{"key":"key-10.7189\/jogh.16.04051-202604301951-R33","doi-asserted-by":"publisher","first-page":"E1611","DOI":"10.1016\/S2214-109X(24)00269-9","article-title":"Respiratory syncytial virus infection among children younger than 2 years admitted to a paediatric intensive care unit with extended severe acute respiratory infection in ten Gavi-eligible countries: the RSV GOLD\u2014ICU Network study.","volume":"12","author":"RSV GOLD\u2014ICU Network collaborators","year":"2024","journal-title":"Lancet Glob Health"},{"key":"key-10.7189\/jogh.16.04051-202604301951-R34","unstructured":"The World Bank Group. Out-of-pocket expenditure (% of current health expenditure) - Cameroon. 2023. Available: https:\/\/data.worldbank.org\/indicator\/SH.XPD.OOPC.CH.ZS?locations=CM. Accessed: 10 April 2024."},{"key":"key-10.7189\/jogh.16.04051-202604301951-R35","doi-asserted-by":"publisher","first-page":"46","DOI":"10.12688\/gatesopenres.13105.2","article-title":"Tetanus vaccine coverage in recommended and more than recommended doses among mothers in a West Cameroon health district: a cross sectional study.","volume":"4","author":"Nguemouo Nguegang","year":"2021","journal-title":"Gates Open Res"},{"key":"key-10.7189\/jogh.16.04051-202604301951-R36","unstructured":"Gavi The Vaccine Alliance. Vaccine Investment Strategy 2018. 2018. Available: https:\/\/www.gavi.org\/our-alliance\/strategy\/vaccine-investment-strategy-2018. Accessed: 11 April 2024."},{"key":"key-10.7189\/jogh.16.04051-202604301951-R37","unstructured":"Gates Foundation. Bill & Melinda Gates Foundation Announces Grants to Reduce Infant Mortality. 2022. Available: https:\/\/www.gatesfoundation.org\/ideas\/media-center\/press-releases\/2022\/09\/gates-foundation-announces-grants-to-reduce-infant-mortality. Accessed: 23 May 2024."},{"key":"key-10.7189\/jogh.16.04051-202604301951-R38","doi-asserted-by":"publisher","first-page":"100379","DOI":"10.1016\/j.jvacx.2023.100379","article-title":"Maternal vaccination against RSV can substantially reduce childhood mortality in low-income and middle-income countries: A mathematical modeling study.","volume":"15","author":"Willemsen","year":"2023","journal-title":"Vaccine X"}],"container-title":["Journal of Global Health"],"original-title":[],"link":[{"URL":"https:\/\/jogh.org\/2026\/jogh-16-04051","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T17:52:45Z","timestamp":1777571565000},"score":1,"resource":{"primary":{"URL":"https:\/\/jogh.org\/2026\/jogh-16-04051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":38,"URL":"https:\/\/doi.org\/10.7189\/jogh.16.04051","relation":{},"ISSN":["2047-2978","2047-2986"],"issn-type":[{"value":"2047-2978","type":"print"},{"value":"2047-2986","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"article-number":"04051"}}